Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 3, Issue 11, Pages 623-636
Publisher
EMBO
Online
2011-09-28
DOI
10.1002/emmm.201100176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant BRAF Melanomas—Dependence and Resistance
- (2011) Poulikos I. Poulikakos et al. CANCER CELL
- The Evolving War on Cancer
- (2011) Daniel A. Haber et al. CELL
- Searching for synthetic lethality in cancer
- (2011) Rachel Brough et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cancer genomics: from discovery science to personalized medicine
- (2011) Lynda Chin et al. NATURE MEDICINE
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
- (2011) A. Aly et al. Journal of Molecular Cell Biology
- Exploiting the balance between life and death: Targeted cancer therapy and “oncogenic shock”
- (2010) Sreenath V. Sharma et al. BIOCHEMICAL PHARMACOLOGY
- Targeting BRAF for patients with melanoma
- (2010) H-T Arkenau et al. BRITISH JOURNAL OF CANCER
- ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
- (2010) David E. Gerber et al. CANCER CELL
- A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
- (2010) Marta Puyol et al. CANCER CELL
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation
- (2010) Kavya Rakhra et al. CANCER CELL
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
- (2010) Samuel F. Bunting et al. CELL
- Targeted Cancer Therapies in the Twenty-First Century: Lessons From Imatinib
- (2010) F Stegmeier et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
- (2010) Vladimir Krystof et al. CURRENT DRUG TARGETS
- The biology and treatment of EML4-ALK non-small cell lung cancer
- (2010) Takaaki Sasaki et al. EUROPEAN JOURNAL OF CANCER
- Synthetic lethality: General principles, utility and detection using genetic screens in human cells
- (2010) Sebastian M.B. Nijman FEBS LETTERS
- Clinical Implications of the Cancer Genome
- (2010) Laura E. MacConaill et al. JOURNAL OF CLINICAL ONCOLOGY
- The GIST paradigm: lessons for other kinase-driven cancers
- (2010) Cristina R Antonescu JOURNAL OF PATHOLOGY
- Translating cancer research into targeted therapeutics
- (2010) J. S. de Bono et al. NATURE
- International network of cancer genome projects
- (2010) Thomas J. Hudson (Chairperson) et al. NATURE
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
- (2010) Peter Bouwman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
- (2009) Anurag Singh et al. CANCER CELL
- Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
- (2009) Claudia Scholl et al. CELL
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
- (2009) Ji Luo et al. CELL
- The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
- (2009) Jaclyn A. Freudenberg et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Shifting paradigms: the seeds of oncogene addiction
- (2009) Charles L Sawyers NATURE MEDICINE
- Attacking cancer at its foundation
- (2009) Nicholas Lydon NATURE MEDICINE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction
- (2009) A. Bertotti et al. Science Signaling
- Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors
- (2008) U. McDermott et al. CANCER RESEARCH
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- Defining the blueprint of the cancer genome
- (2008) V. E. Velculescu CARCINOGENESIS
- Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
- (2008) J. A. Engelman et al. CLINICAL CANCER RESEARCH
- Acquired resistance to tyrosine kinase inhibitors during cancer therapy
- (2008) Jeffrey A Engelman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Targeted therapy for cancer using PARP inhibitors
- (2008) Christopher J Lord et al. CURRENT OPINION IN PHARMACOLOGY
- Translating insights from the cancer genome into clinical practice
- (2008) Lynda Chin et al. NATURE
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
- EGFR Tyrosine Kinase Inhibitors in Lung Cancer: An Evolving Story
- (2007) Lecia V. Sequist et al. Annual Review of Medicine
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now